DKK3 and cancer: Since REIC/Dkk-3 expression is significantly downregulated in several human cancer cells, but is typically expressed in non-malignant or normal cells (15,16,18,21), the endogenous expression levels of the protein seem to be correlated with the sensitivity of the cells against the REIC/Dkk-3 overexpression by Ad-REIC.